HIT Consultant April 2, 2024
Fred Pennic

What You Should Know:

Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.

– Built in collaboration with Mayo Clinic, the AI allows U.S. healthcare providers to detect Low Ejection Fraction (LVEF), a crucial indicator of heart failure, in just 15 seconds using a standard Eko stethoscope during a routine physical exam.

Importance of Early Detection

The advancement in early detection signifies a major medical innovation for cardiovascular disease. In the US alone, over 6 million individuals struggle with heart failure, with half experiencing HFrEF, a condition where the heart cannot pump blood efficiently. Traditionally, diagnosing heart failure often relies on echocardiography, a tool unavailable in many...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Patient / Consumer, Physician, Provider, Technology
OpenAI CEO Sam Altman: Company Considering ‘Different Open-Source Strategy’
Chinese AI app DeepSeek was downloaded by millions. Deleting it might come next
Forget Billion-Dollar Companies—Will AI Create Billion-Dollar People?
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
The future of cardiac monitoring: AI-powered wearables in practice

Share This Article